ATE382687T1 - METHOD FOR SITE-DIRECTED MUtagenesis and TARGETED RANDOMIZATION - Google Patents

METHOD FOR SITE-DIRECTED MUtagenesis and TARGETED RANDOMIZATION

Info

Publication number
ATE382687T1
ATE382687T1 AT04703064T AT04703064T ATE382687T1 AT E382687 T1 ATE382687 T1 AT E382687T1 AT 04703064 T AT04703064 T AT 04703064T AT 04703064 T AT04703064 T AT 04703064T AT E382687 T1 ATE382687 T1 AT E382687T1
Authority
AT
Austria
Prior art keywords
site
directed mutagenesis
targeted randomization
randomization
targeted
Prior art date
Application number
AT04703064T
Other languages
German (de)
Inventor
Chris Leeflang
Der Kleij Wilhelmus Van
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32771864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE382687(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genencor Int filed Critical Genencor Int
Application granted granted Critical
Publication of ATE382687T1 publication Critical patent/ATE382687T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides methods and compositions for the construction and direct transformation of site-saturation libraries into Bacillus. This method avoids the need for the use of intermediate hosts, such as E. coli for the development of Bacillus strains suitable for the production of proteins.
AT04703064T 2003-01-16 2004-01-16 METHOD FOR SITE-DIRECTED MUtagenesis and TARGETED RANDOMIZATION ATE382687T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44079203P 2003-01-16 2003-01-16

Publications (1)

Publication Number Publication Date
ATE382687T1 true ATE382687T1 (en) 2008-01-15

Family

ID=32771864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04703064T ATE382687T1 (en) 2003-01-16 2004-01-16 METHOD FOR SITE-DIRECTED MUtagenesis and TARGETED RANDOMIZATION

Country Status (7)

Country Link
US (1) US20060252155A1 (en)
EP (1) EP1587924B2 (en)
AT (1) ATE382687T1 (en)
CA (1) CA2513227C (en)
DE (1) DE602004011017T3 (en)
DK (1) DK1587924T4 (en)
WO (1) WO2004064744A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2743123A1 (en) 2008-11-11 2010-05-20 Danisco Us Inc. Compositions and methods comprising a subtilisin variant
AR074104A1 (en) 2008-11-11 2010-12-22 Danisco Us Inc COMPOSITIONS AND METHODS THAT INCLUDE SUBTILISIN VARIANTS
EP2558573B1 (en) 2010-04-15 2017-02-22 Danisco US Inc. Compositions and methods comprising variant proteases
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182204A (en) * 1984-05-29 1993-01-26 Genencor International, Inc. Non-human carbonyl hydrolase mutants, vectors encoding same and hosts transformed with said vectors
US5418873A (en) * 1993-09-09 1995-05-23 Digisonix, Inc. Active acoustic attenuation system with indirect error sensing
US5693506A (en) 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
WO2003054234A1 (en) * 2001-12-19 2003-07-03 Roche Diagnostics Corporation Pcr based high throughput polypeptide screening

Also Published As

Publication number Publication date
WO2004064744A2 (en) 2004-08-05
DK1587924T3 (en) 2008-05-13
EP1587924A2 (en) 2005-10-26
WO2004064744A3 (en) 2004-11-04
EP1587924B2 (en) 2012-01-18
DK1587924T4 (en) 2012-04-02
DE602004011017D1 (en) 2008-02-14
CA2513227C (en) 2012-09-11
DE602004011017T2 (en) 2008-12-24
CA2513227A1 (en) 2004-08-05
DE602004011017T3 (en) 2012-06-06
EP1587924A4 (en) 2006-05-10
EP1587924B1 (en) 2008-01-02
US20060252155A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
IL226717A (en) Isolated nucleic acids encoding humanized anti-beta7 antibodies
TW200732349A (en) Anti-OX40L antibodies and methods using same
MY151036A (en) Synthesis of (r)-n-methylnaltrexone
NO20063193L (en) Fused pyrrolocarbazoles and processes for their preparation
ATE497492T1 (en) CLEANING MONTELUKAST
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
ATE554105T1 (en) ALTERED ANTIBODIES
ATE537263T1 (en) CATIONIC LIPIDS AND METHODS OF USE
TW200716646A (en) (S)-N-methylnaltrexone
WO2006127757A3 (en) Interferon-igg fusion
MY144970A (en) Heterocyclic compounds
CY1110214T1 (en) METHODS AND INTERMEDIATES
NO20076413L (en) Multicyclic compounds and methods for their use
MX2020007018A (en) Il-22 fc fusion proteins and methods of use.
BRPI0414599A (en) substituted pyrrol indoles
MX2009004862A (en) Stabilization of vaccines by lyophilization.
WO2004032882A3 (en) Chemical compounds
ATE448775T1 (en) RIFALAZIL FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS
PL1668001T3 (en) Substituted heteroaryl benzofuran acids
EA200800570A1 (en) PHOSPHONIC RIFAMYCINES AND THEIR APPLICATION FOR PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
PH12013502194A1 (en) Antibodies to egfl7 and methods for their use
ATE543833T1 (en) BMP-7 VARIANT COMPOSITIONS, METHODS AND USES
WO2005040107A3 (en) Methods for making simvastatin and intermediates
TW200621744A (en) Mercaptoamides as histone deacetylase inhibitors
MXPA03007413A (en) Composition and method for treating inflammatory disorders.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties